Cabgolin 0.5mg
Generic: Cabergolineby Sun Pharmaceutical Industries Ltd

Similar medicines
View allAbout Cabgolin 0.5mg
Cabgolin 0.5 is a Sun Pharma tablet containing 0.5 mg of cabergoline, a dopamine agonist that lowers the hormone prolactin. Doctors prescribe it for hyperprolactinaemia: raised prolactin with no known cause or from a prolactin-secreting pituitary tumour. It is a weekly medicine, usually taken once or twice a week, never every day. We stock it in packs of 12 and 24 tablets, from $1.35 a tablet before shipping in the 24 pack.
Before you order, know three things. First, cabergoline is started only after a heart check: the US label asks for an echocardiogram (an ultrasound scan of the heart) before treatment, because cabergoline can scar heart valves. Second, Cabgolin 0.5 is the cheapest Sun Pharma cabergoline 0.5 mg tablet we sell, at about half the per tablet price of our Caberlin 0.5mg. Third, if you live in the US and have a prescription, generic cabergoline 0.5 mg costs US pharmacies about $1.29 a tablet, close to our 24 pack price before shipping and below it once our $25 shipping is added. Doses, warnings and figures below come from the current US cabergoline label, the UK Dostinex label and the Canadian Dostinex monograph, listed under Sources.
Cabgolin 0.5 at a glance
| Active ingredient | Cabergoline 0.5 mg in each tablet; cabergoline is an ergot derivative |
| Brand and maker | Cabgolin, Sun Pharma. PharmEasy names Sun Pharma Laboratories Ltd, Setipool, East Sikkim, as manufacturer; Truemeds names Sun Pharma Laboratories Ltd |
| Regulatory status | Cabergoline is licensed in the US (generic tablets), the UK, Australia and Canada (Dostinex and generics). This Indian Cabgolin pack is not registered with the FDA, MHRA, TGA or Health Canada |
| Usual dose from the label | UK and Canada: 0.5 mg a week to start (one Cabgolin 0.5 tablet, or two half doses), usually 1 mg a week. US: 0.25 mg twice weekly to start, maximum 1 mg twice weekly |
| Half-life | 63 to 69 hours in 12 healthy people (US label 12.3). The UK label says a single dose lowers prolactin within 3 hours, and the effect lasts 7 to 28 days in people with high prolactin (5.1) |
| Packs | 12 and 24 tablets; Indian strips hold 4 tablets (Truemeds, PharmEasy) |
| Price per tablet | $1.75 (12 pack) and $1.35 (24 pack), before shipping |
| Delivery | 7 to 14 business days to the US, UK, Australia and Canada; $25 shipping on orders under $149, free from $149 |
Price per tablet
Prices are as of November 2026; the pack selector shows the current price.
| Pack | Price | Per tablet | Shipping | Per tablet with shipping |
|---|---|---|---|---|
| 12 tablets | $21.00 | $1.75 | $25 | $3.83 |
| 24 tablets | $32.50 | $1.35 | $25 | $2.40 |
Neither pack reaches the $149 free shipping threshold on its own, so a single pack pays $25 shipping. The 24 pack is the better buy per tablet whether or not you count shipping. Shipping is charged per order, not per pack, so combining a 24 pack with other items in one order spreads that $25 further.
How long a pack lasts. Our arithmetic, not a label figure, assuming your doctor has already settled the dose:
- 0.5 mg a week (the UK and Canadian starting dose, one tablet a week): 12 weeks from the 12 pack, 24 weeks from the 24 pack.
- 1 mg a week (the usual UK and Canadian dose, one tablet twice a week): 6 weeks and 12 weeks.
- 1 mg twice weekly (the US maximum, four tablets a week): 3 weeks and 6 weeks.
Check that the expiry date printed on the strip covers the weeks you need before you open a second strip.
Other cabergoline 0.5 mg tablets we sell, per tablet before shipping: Caberlin 0.5mg (also Sun Pharma) $2.74 to $3.50, CB-Lin 0.5mg $2.86 to $3.75, and Cabanex 0.5mg $0.77 to $0.82 in packs of 100 and 200. Cabanex is made by Actiza Pharma, a maker connected to SafeRxPills; its packs are far larger than most people need in one go, so weigh the low price against the expiry date. In India, Cabgolin 0.5 and Caberlin 0.5 carry the same printed price (MRP Rs 566 for a strip of 4 on Truemeds and PharmEasy for Cabgolin, and on the same pharmacies for Caberlin). We have no data on whether the two Sun Pharma brands use the same formula, so we do not call them identical.
Compared with US generic cabergoline
| Cabgolin 0.5 (ours) | US generic cabergoline 0.5 mg | |
|---|---|---|
| Maker | Sun Pharma, India | Several US generic makers |
| FDA approved | No (this Indian pack is not registered with the FDA) | Yes, prescription only |
| Cost per tablet | $1.35 to $1.75 before shipping; $2.40 to $3.83 with shipping on a single pack | About $1.29 (NADAC $1.28924, what pharmacies pay) |
| 24 tablets | $32.50 before shipping | About $30.94 at the NADAC rate |
NADAC (National Average Drug Acquisition Cost) is a US Medicaid survey of what pharmacies pay wholesalers. It is not a shelf price, and a US pharmacy will add its own margin. Every one of the seven NDC rows for cabergoline 0.5 mg tablets in the NADAC file dated 4 November 2026 shows $1.28924 a tablet, effective 21 October 2026. By our arithmetic, our price before shipping is about 1.05 to 1.36 times that rate, and about 1.9 to 3.0 times it once $25 shipping is spread over a single pack. A US reader with insurance or a discount card may well pay less locally, so compare cash prices before you order from us.
In the US, cabergoline is sold as a 0.5 mg tablet: the label we used lists only that strength, and NADAC has rows only for 0.5 mg. Pfizer's brand, Dostinex, is listed in the FDA Orange Book as discontinued, with a Federal Register determination that it was not withdrawn for safety or effectiveness reasons. US generics were approved on bioequivalence to Dostinex. We have seen no study comparing the Indian Cabgolin tablet with Dostinex or with US generics.
Which strength to choose
Your doctor sets the dose from prolactin blood tests. This table shows how each dose is made up from the tablets we sell.
| Dose | Tablets | Where it sits in the labels |
|---|---|---|
| 0.25 mg twice weekly | One Cabgolin 0.25mg or Caberlin 0.25mg each time | US starting dose |
| 0.5 mg once a week | One Cabgolin 0.5 | UK and Canadian starting dose given as a single weekly dose |
| 0.5 mg twice weekly (1 mg a week) | One Cabgolin 0.5 each time | Usual UK and Canadian dose; in the US, a step up made no sooner than 4 weeks after starting |
| 0.75 mg twice weekly | One Cabgolin 0.5 plus one 0.25 mg tablet each time | A later US step |
| 1 mg twice weekly (2 mg a week) | Two Cabgolin 0.5 each time | US maximum; top of the UK range of 0.25 to 2 mg a week |
| Above 1 mg twice weekly | None | Above the US labelled maximum; the UK label says up to 4.5 mg a week "have been used" |
Splitting a 0.5 mg tablet. The UK label describes a 0.25 mg dose as "one-half of one 0.5 mg tablet", and the UK and US 0.5 mg tablets are scored. We could not confirm from the Indian listings or our product photo whether the Cabgolin 0.5 tablet has a score line, and Truemeds says crushing or splitting it is "generally not recommended unless advised by your doctor". If your dose is 0.25 mg, use a 0.25 mg tablet rather than cutting this one.
One weekly dose or two. The UK label allows the weekly dose to be taken at once or split over the week, but advises splitting it once the weekly dose is above 1 mg, because the tolerability of more than 1 mg as a single weekly dose "has been evaluated only in a few patients". Increases in the UK label are by 0.5 mg a week at monthly intervals; the US label raises by 0.25 mg twice weekly, again no sooner than every 4 weeks.
What the trials found at 0.5 mg twice weekly
Cabgolin 0.5 matches the dose used in the US label's main comparison trial (Study 2): 0.5 mg twice weekly against bromocriptine 2.5 mg twice daily for 8 weeks in women with high prolactin and absent periods. At 8 weeks:
| Outcome at 8 weeks | Cabergoline 0.5 mg twice weekly | Bromocriptine 2.5 mg twice daily |
|---|---|---|
| Normal prolactin | 77% | 59% |
| Periods returned | 77% | 70% |
| Breast milk discharge stopped | 73% | 56% |
The label notes attrition of 46% and 43% in the two groups. In the 4 week placebo-controlled dose study (Study 1), 76% of women on 0.5 mg twice weekly (after a first week at 0.25 mg) reached normal prolactin, against 0% on placebo and 95% on 1 mg twice weekly (after a first week at 0.5 mg). The label adds that how well cabergoline keeps working "beyond 24 months of therapy has not been established". These are group results; your own response is judged by your blood tests.
How to take Cabgolin 0.5
- Days, not hours. Take it on the fixed day or days your doctor gives you, for example Monday and Thursday, the example in the UK label. Some Indian listings, including Truemeds, carry text about taking it "at a fixed time every day"; that does not match any of the labels we used, which give cabergoline once or twice a week.
- Food. The UK label recommends taking it preferably with meals, because this class of medicine is better tolerated with food. The US label says with or without food, and found that a high fat meal did not change absorption.
- Swallow it whole with water, as Truemeds advises for this tablet.
- Getting up. Rise slowly from lying or sitting. The US label tells patients to report dizziness or light-headedness when they change position, and the UK label says to take care with driving or using machines in the first days of treatment.
- Missed dose. The Canadian monograph says take it as soon as possible, unless the next dose is close (for example 1 day away), in which case skip it. "Do not double doses."
- Blood tests. The US patient information says your prolactin should be checked about every 4 weeks at first, then periodically.
- Storage. Truemeds lists Cabgolin 0.5 as "Store Below 25°C"; PharmEasy says a cool, dry place away from sunlight and moisture. The UK Dostinex label and healthdirect Australia also say below 25 °C.
- Stopping. The UK label says high prolactin usually returns after cabergoline is stopped, though in some people it stays low for months: in one group, 23 of 29 women kept ovulating for more than 6 months after stopping. The US label asks doctors to recheck prolactin periodically to decide whether to restart.
Heart scans and fibrosis
Cabergoline can cause fibrosis, a stiffening and scarring of tissue, in the heart valves, the sac around the heart (pericardium), the lining of the lungs, the lungs and the space behind the abdomen. This is why the labels attach scans and tests to every prescription.
- Before the first tablet. The US label (2.1, 5.1) asks for a cardiovascular evaluation including an echocardiogram, and says not to give cabergoline if valve disease is found.
- During treatment. The US label (5.1) advises a repeat echocardiogram every 6 to 12 months, or sooner with new swelling, a heart murmur, breathlessness or heart failure. For long-term use, the UK label and the Canadian monograph say the first follow-up scan must come within 3 to 6 months and then at least every 6 to 12 months.
- Other baseline tests. The US label (5.2) suggests erythrocyte sedimentation rate (an inflammation marker), serum creatinine and a chest X-ray at baseline and as needed.
- When to stop. The US label says to stop cabergoline on a new diagnosis of valve regurgitation, valve restriction, leaflet thickening or pericarditis, and if pleural, pericardial, retroperitoneal or lung fibrosis occurs.
The US label says most valve cases were reported with high doses, more than 2 mg a day, used for Parkinson's disease, which is not an approved use, but that cases have also been reported in people taking lower doses for high prolactin. Its 12 year cohort study in Parkinson's disease found valve regurgitation at 68 per 10,000 person years with cabergoline, against 10 with non-ergot dopamine agonists and 11 with levodopa. The UK label says valve disease "has been associated with cumulative doses", so patients "should be treated with the lowest effective dose". Do not buy cabergoline from us, or anyone, to skip these checks.
People who need extra care
- Liver problems. US label: in severe liver impairment (Child-Pugh C) cabergoline "is not recommended"; in moderate impairment (Child-Pugh B), watch more closely for side effects. Exposure rose 1.5 times in moderate and 5.6 times in severe impairment (US 8.6, 12.3). The UK label lists hepatic insufficiency as a contraindication.
- Blood pressure tablets. The US label (5.3) says the risk of dizziness and low blood pressure on standing is greater with medicines that lower blood pressure, and asks for blood pressure checks at baseline and during treatment.
- Other medicines linked to valve disease. US 5.1: use cabergoline with them only if its benefit outweighs the risk.
- Women who do not want to become pregnant. Lowering prolactin can restart ovulation before periods return. The UK label recommends a pregnancy test at least every four weeks while periods are absent, and whenever a period is more than three days late once they restart, and advises mechanical contraception for women who wish to avoid pregnancy, during treatment and after stopping until ovulation stops again.
- Older adults. The US label says trials did not include enough people aged 65 and over to show whether they respond differently.
- Kidney problems. The US label found no change in cabergoline levels in 12 people with moderate to severe kidney impairment; the UK label still advises caution.
Side effects at this dose
| Side effect | Cabergoline 0.5 mg twice weekly (n=221) | Bromocriptine 2.5 mg twice daily (n=231) |
|---|---|---|
| Nausea | 29% | 43% |
| Headache | 26% | 27% |
| Dizziness | 17% | 18% |
| Constipation | 7% | 9% |
| Asthenia (weakness) | 6% | 6% |
| Abdominal pain | 5% | 8% |
| Dyspepsia | 5% | 7% |
| Fatigue | 5% | 8% |
| Vomiting | 4% | 7% |
| Depression | 3% | 2% |
| Hot flashes | 3% | 1% |
Selected rows from US label Table 2, the 8 week double-blind period of Study 2 in women with high prolactin. There was no placebo group in this trial. In it, 2% of women on cabergoline (4 of 221) stopped because of a side effect, against 6% on bromocriptine; headache, nausea and vomiting were the usual reasons. In the separate 4 week placebo trial (US Table 1), dizziness affected 15% on cabergoline against 5% on placebo, and low blood pressure on standing 4% against 0%.
Urges you cannot control. The US label (5.5) warns of intense urges to gamble or spend money, increased sexual urges, binge eating and other urges, and says patients may not see these as abnormal. Tell your doctor about any new or stronger urges; the label says a lower dose or stopping should be considered, and that in some cases the urges stopped when this was done. A partner or family member may notice them first.
Other effects in the labels. After approval, reports have included hypersexuality, pathological gambling, psychotic disorder, aggression and hair loss (US 6.2). The UK label lists heart valve disease as very common, and includes sleepiness, depression, sudden sleep onset, digital vasospasm (narrowing of the blood vessels in the fingers) and angina among other effects. The UK label says anyone who has had sleepiness or an episode of sudden sleep onset must not drive or operate machines until these episodes have resolved.
When to get urgent help
Our advice: get emergency care, or have someone call for you, if you notice:
- Chest pain, breathlessness, difficulty breathing when lying flat, a persistent cough, or new swelling of your legs or arms. The US patient information says to call your health care provider right away about these, as possible signs of valve damage or fibrosis; going to emergency care when they are severe or sudden is our advice.
- Fainting, or dizziness that does not ease when you sit or lie down.
- After giving birth: a severe, progressive or unremitting headache, with or without changes in vision, chest pain, or high blood pressure. The UK label reports high blood pressure, heart attack, seizures, stroke and psychiatric disorders in women given cabergoline after delivery, sometimes preceded by severe headache or brief vision changes.
- Swelling of the lips, tongue, face or throat, trouble breathing or swallowing, hives or a spreading rash, which can be signs of a serious allergic reaction.
- Hallucinations, confusion or losing touch with reality.
- Taking more than you were prescribed. The US patient information says to call Poison Help on 1-800-222-1222 or go to the nearest emergency room right away; the UK label lists nausea, vomiting, low blood pressure on standing, confusion, psychosis and hallucinations as likely overdose effects.
Tell the staff that you take cabergoline (Cabgolin 0.5), how many tablets and when you took the last one.
Who should not take Cabgolin 0.5
The labels say never take it if you have:
- uncontrolled high blood pressure (US 4; Canadian monograph)
- a known allergy to ergot derivatives (US 4), or to cabergoline or any ingredient of the tablet (UK 4.3; Canada)
- a history of heart valve disorders on pre-treatment scans, or pericardial fibrosis (US 4); for long-term use, the UK label names valvulopathy on the pre-treatment echocardiogram
- a history of pleural, pulmonary or retroperitoneal fibrosis (US 4); the UK label (4.3) names pulmonary, pericardial and retroperitoneal fibrotic disorders
- hepatic insufficiency, toxaemia of pregnancy (pre-eclampsia), or a history of psychosis after childbirth (UK 4.3)
- a prescription for antipsychotic medicine: the UK label (4.3) says cabergoline "should not be co-administered with anti-psychotic medications"
The labels advise against it, or ask for caution:
- Dopamine blocking medicines. US 7: "not recommended" with phenothiazines, butyrophenones, thioxanthenes or metoclopramide. UK 4.5: it "should not be concurrently administered" with dopamine antagonists, such as phenothiazines, butyrophenones, thioxanthenes and metoclopramide, because they might reduce its prolactin-lowering effect.
- Erythromycin and other macrolide antibiotics. UK 4.5: cabergoline "should not be used with macrolide antibiotics (e.g. erythromycin)", which raise its blood levels. Long-term use with other ergot alkaloids is not recommended.
- Pregnancy. The US label says to avoid dopamine agonists in general during pregnancy and after delivery, with higher risk in pregnancy-induced hypertension, pre-eclampsia and eclampsia. The UK label says to stop cabergoline once pregnancy is confirmed. Tell your doctor straight away if you could be pregnant.
- Breastfeeding. US 8.2: "not recommended in postpartum women who are breastfeeding or who are planning to breastfeed".
- Heart, circulation, stomach and mental health history. The UK label advises caution with severe heart disease, Raynaud's syndrome, peptic ulcer or stomach bleeding, and a history of serious mental illness.
- Lactose. The US tablet contains lactose, and the UK label says people with rare hereditary galactose problems should not take tablets containing it. We could not find the Indian Cabgolin excipient list; read the carton.
- Children. Safety and effectiveness are not established (US 8.4; UK label, under 16).
Stopping breast milk after birth
The labels do not agree on this use. The UK and Canadian labels license a single 1 mg dose (two 0.5 mg tablets) on the first day after delivery to prevent milk, and the UK label also licenses 0.25 mg every 12 hours for two days to stop milk that has already started. The UK label warns that a single 0.25 mg dose should not be exceeded when stopping established milk, because a single 0.5 mg dose roughly doubled the risk of side effects. The US label says to avoid cabergoline for this purpose "because of the risk of serious adverse reactions". After a birth, this is for the doctor or midwife looking after you, with blood pressure checks; please do not use tablets ordered online for it.
None of the labels lists any use in sports, bodybuilding or sexual performance, and we do not advise cabergoline for these.
Prescription and legal status
Cabergoline needs a prescription in every country we ship to. US: generic cabergoline tablets are FDA approved and "Rx only"; the FDA says personal importation of drugs is "illegal in most circumstances". UK: Dostinex is a prescription only medicine (emc). Australia: healthdirect lists Dostinex as Schedule 4, Prescription Only Medicine. Canada: Dostinex, Apo-Cabergoline and Jamp Cabergoline are marketed prescription drugs (Health Canada Drug Product Database). India: Truemeds marks Cabgolin 0.5 "Prescription required", PharmEasy describes it as a prescription medicine, and the carton in our product photo carries the Rx symbol. Check the rules where you live before ordering.
Buying genuine Cabgolin
The carton in our product photo reads "Cabgolin 0.5", "Cabergoline Tablets IP" and "2 X 4 Tablets", with the Sun Pharma logo, and the blister holds 4 round tablets. Our packs are counted in tablets, so expect strips of 4. When your order arrives, check the strip for the Cabgolin 0.5 name, the cabergoline 0.5 mg strength, a batch number and an expiry date. These checks cannot prove that tablets are genuine, because packaging can be copied. Falling prolactin on your blood tests is the practical sign that the medicine is working.
The MHRA warns that "Any medicine not authorised for sale in the UK can be unsafe or ineffective and there is no way of knowing what is in them or the negative health effects they can have", and tells UK buyers to "Only use UK-registered pharmacies, including online pharmacies displaying the official green cross logo". That warning applies to this Indian pack. If a batch causes unexpected symptoms, get medical advice and report it to the MHRA Yellow Card scheme, FDA MedWatch, the TGA or Health Canada, as well as to us.
Delivery
Cabgolin 0.5 ships to the US, UK, Australia and Canada in plain packaging with tracking, in 7 to 14 business days. Orders under $149 pay a flat $25 for shipping; orders from $149 ship free. Because your dose is set by blood tests every few weeks at first, order once the dose is stable and allow two weeks for delivery. Details are on our shipping page and in our refund policy.
Related guides
- Cabergoline (Caberlin): what it treats, how to dose it, and what to watch for
- Clomid side effects and fertility treatment, which explains why high prolactin is checked and treated before ovulation drugs
- Provera and the progestin withdrawal bleed, which covers raised prolactin as one cause of missing periods
Other cabergoline products: Cabgolin 0.25mg, Caberlin 0.5mg, Caberlin 0.25mg, CB-Lin 0.5mg and Cabanex 0.5mg.
Sources
- Cabergoline tablets, US prescribing information and Patient Information, Mylan Pharmaceuticals (Greenstone brand), revised June 2026 (DailyMed setid e497366b-a124-4d7f-bd45-a883c392d4bb, version 12, published 1 July 2026; checked current 10 November 2026): sections 1, 2.1, 2.2, 3, 4, 5.1 to 5.5, 6.1 (Tables 1 and 2), 6.2, 7, 8.1, 8.2, 8.4 to 8.6, 10, 11, 12.3, 14, 16, 17 and Patient Information. DailyMed
- Dostinex 0.5 mg tablets, UK Summary of Product Characteristics, Pfizer Limited, updated 20 September 2024: sections 4.1 to 4.9, 5.1, 5.2, 6.4. emc
- Dostinex (cabergoline) tablets 0.5 mg, Canadian Product Monograph, Pfizer Canada ULC, revised 21 August 2025: contraindications, warnings and precautions, dosage (missed dose), storage. Pfizer Canada
- Centers for Medicare and Medicaid Services, National Average Drug Acquisition Cost (NADAC) 2026: cabergoline 0.5 mg tablet $1.28924 per tablet, 7 NDC rows, effective 21 October 2026, file as of 4 November 2026 (latest on 10 November 2026); no Dostinex rows. data.medicaid.gov
- US Food and Drug Administration, Orange Book: Dostinex NDA 020664 discontinued, Federal Register determination that it was not discontinued for safety or effectiveness reasons.
- Health Canada Drug Product Database: Dostinex, Apo-Cabergoline and Jamp Cabergoline, marketed, prescription. Health Canada
- healthdirect Australia: Dostinex (cabergoline 500 microgram), Schedule 4, store below 25 °C. healthdirect
- Indian pharmacy listings for Cabgolin 0.5 (Truemeds and PharmEasy: maker, strip of 4, MRP, storage, prescription status, directions), read 10 November 2026.
- MHRA. 20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys, 13 February 2026. GOV.UK
- US Food and Drug Administration. Personal Importation. FDA
This page is information, not medical advice. Cabergoline is a prescription medicine. Take Cabgolin 0.5 only as prescribed by a doctor who checks your prolactin, heart and blood pressure, and do not start, stop or change your dose on your own.
Frequently asked questions
What is Cabgolin 0.5?
Cabgolin 0.5 is a Sun Pharma tablet from India containing 0.5 mg of cabergoline, a dopamine agonist that lowers prolactin. It is prescribed for hyperprolactinaemia, either with no known cause or from a prolactin-secreting pituitary tumour. It is taken once or twice a week, not daily.
Is Cabgolin 0.5 the same as Caberlin 0.5?
Both are Sun Pharma brands of cabergoline 0.5 mg, sold in India in strips of 4 at the same printed price (MRP Rs 566 on Truemeds and PharmEasy). We have no data on whether they share a formula, so we do not call them identical. With us, Cabgolin 0.5 costs about half as much per tablet as Caberlin 0.5.
How much does Cabgolin 0.5 cost per tablet?
As of November 2026, $1.75 a tablet in the 12 pack ($21.00) and $1.35 in the 24 pack ($32.50), before shipping; the pack selector shows the current price. Shipping is $25 on orders under $149, which brings a single pack to $3.83 or $2.40 a tablet. US pharmacies pay about $1.29 a tablet for generic cabergoline 0.5 mg (NADAC, effective 21 October 2026).
How often do I take Cabgolin 0.5?
Only on the days your doctor sets, usually once or twice a week, for example Monday and Thursday. The UK and Canadian labels start at 0.5 mg a week (one tablet) and usually settle at 1 mg a week (one tablet twice a week). The US label starts lower, at 0.25 mg twice weekly. Ignore any listing that says to take it every day.
Can I split Cabgolin 0.5 to take 0.25 mg?
The UK label describes 0.25 mg as half of a scored 0.5 mg tablet, but we could not confirm that the Cabgolin 0.5 tablet has a score line, and Truemeds says splitting is generally not recommended unless your doctor advises it. For a 0.25 mg dose, use Cabgolin 0.25mg or Caberlin 0.25mg instead.
How well does 0.5 mg twice weekly work?
In the US label's 8 week trial of cabergoline 0.5 mg twice weekly against bromocriptine in women with high prolactin and absent periods, 77% on cabergoline reached normal prolactin (59% on bromocriptine), 77% had periods return (70%) and 73% stopped producing breast milk (56%). Your own response is judged by your blood tests.
Do I need heart scans while taking cabergoline?
Yes. The US label asks for an echocardiogram before starting and says not to give cabergoline if valve disease is found, then a repeat scan every 6 to 12 months or sooner with symptoms. For long-term use, the UK label and Canadian monograph say the first follow-up scan must come within 3 to 6 months, then at least every 6 to 12 months.
What side effects are common at 0.5 mg twice weekly?
In the US label's 8 week trial at this dose, nausea affected 29%, headache 26%, dizziness 17%, constipation 7%, and abdominal pain, dyspepsia and fatigue 5% each; 2% stopped because of a side effect. Serious risks include heart valve damage (listed as very common in the UK label), fibrosis, low blood pressure on standing and uncontrollable urges such as gambling or spending.
Who should not take Cabgolin 0.5?
The US label rules it out with uncontrolled high blood pressure, allergy to ergot derivatives, a history of heart valve disorders or pericardial fibrosis, and a history of pleural, pulmonary or retroperitoneal fibrosis. The UK label adds hepatic insufficiency, toxaemia of pregnancy, a history of psychosis after childbirth and use with antipsychotic medicines. The US label says it is not recommended when breastfeeding.
Do I need a prescription for Cabgolin 0.5?
Cabergoline is prescription only in the US, UK, Australia (Schedule 4) and Canada, and Indian pharmacies list Cabgolin 0.5 as a prescription medicine. The FDA says personal importation of drugs is illegal in most circumstances. This Indian pack is not registered with the FDA, MHRA, TGA or Health Canada.
How long does delivery take, and how long will a pack last?
Delivery to the US, UK, Australia and Canada takes 7 to 14 business days in plain, tracked packaging; shipping is $25 under $149 and free from $149. By our arithmetic, at one tablet twice a week the 12 pack lasts 6 weeks and the 24 pack 12 weeks; at one tablet a week, 12 and 24 weeks.
Medical References
- 1.Cabergoline tablets, US prescribing information and Patient Information, Mylan (Greenstone), revised June 2026 (DailyMed SPL version 12) — 2026
- 2.Dostinex 0.5 mg Tablets, UK Summary of Product Characteristics (Pfizer Limited, PL 00057/0969, POM) — 2024
- 3.Dostinex (cabergoline) 0.5 mg, Canadian Product Monograph, Pfizer Canada ULC, revised 21 August 2025 — 2025
- 4.CMS National Average Drug Acquisition Cost (NADAC) 2026, file as of 4 November 2026 — 2026
- 5.healthdirect Australia: Dostinex (cabergoline 500 microgram), Schedule 4
- 6.US Food and Drug Administration: Personal Importation
Sources: U.S. National Library of Medicine (DailyMed, PubMed), openFDA
Related articles
Customer Reviews
No reviews yet. Bought Cabgolin 0.5mg? Tell other buyers how it went.







